Showing results (321-330 of 383) with videos related to

Sort By:
Pageof 39
Bone Marrow Transplantation|April 9, 2013
CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CMLS Ito, P Pophali, Wu CO, et al.
Leukemia Research|January 1, 1990
Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: a pilot studyD Macdonald, Y Z Jiang, A A Gordon, et al.
Blood|August 9, 2001
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndromeM Stetler-Stevenson, D C Arthur, N Jabbour, et al.
British Journal of Haematology|July 1, 1992
Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five casesJ O Cullis, D I Marks, A P Schwarer, et al.
Blood|September 6, 2001
Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arraysY T Lee, L D Miller, A N Gubin, et al.
Leukemia|June 13, 2008
Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapyA S M Yong, K Keyvanfar, R Eniafe, et al.
Bone Marrow Transplantation|November 25, 1998
High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporineR Childs, C Sanchez, H Engler, et al.
Bone Marrow Transplantation|October 1, 1994
Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactionsA R Datta, A J Barrett, Y Z Jiang, et al.
Immunology|March 1, 1996
Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-AY Z Jiang, D Couriel, D A Mavroudis, et al.
British Journal of Haematology|September 1, 1986
Prediction and prevention of relapse of acute lymphoblastic leukaemia after bone marrow transplantationA J Barrett, R Joshi, J R Kendra, et al.
Pageof 39